UNITED STATES

SECURITIES AND EXCHANGE COMMISSION ~~Washington, D.C. 20549~~

~~Form~~Washington, ~~6-K~~D.C. 20549

~~REPORT~~FORM ~~OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a~~6-16K ~~OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934~~

~~For~~Report ~~the month~~ of ~~August~~Foreign ~~2025.~~Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of September 2025

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

~~On August 15, 2025,~~ Cellebrite DI Ltd. (the “~~Registrant~~Company” or the “~~Company~~Registrant”) ~~announced~~hereby announces that the shareholders of the Company’s ~~Annual~~approved ~~General~~all of ~~Meeting~~the proposals brought before the annual general meeting of ~~its~~shareholders ~~Shareholders~~held on September 19, 2025 (the “~~Annual General~~ Meeting”), by ~~will~~the berespective ~~held~~requisite onmajority ~~Friday,~~in ~~September~~accordance 19with the Israeli Companies Law, ~~2025~~5759-1999, atand ~~4:00~~the ~~p.m.~~Company’s ~~Israel~~articles ~~time~~of association, as atdescribed in the Proxy Statement which was attached as Exhibit 99.1 to the Company’s ~~offices~~Report atof 94Foreign ~~Shlomo~~Private Issuer on ~~Shmelzer~~Form ~~Road~~6-K, ~~Petah~~furnished ~~Tikva~~to ~~4970602,~~the ~~Israel.~~Securities Inand ~~connection~~Exchange ~~with~~Commission (the ~~Annual~~“SEC”) ~~General~~on ~~Meeting~~August 15, ~~the~~2025, ~~Company~~and ~~hereby~~sent ~~furnishes~~in connection with the ~~following documents:~~Meeting.

i.188,039,771 ~~Notice~~ordinary shares, ~~and~~representing ~~Proxy~~approximately ~~Statement~~76.82% ~~with~~of ~~respect to~~ the ~~Annual~~issued ~~General~~and ~~Meeting~~outstanding ~~describing~~ordinary ~~the~~shares ~~proposals~~as toof ~~be voted upon at~~ the ~~meeting~~record date, ~~the~~were ~~procedure~~present ~~for voting in person~~ or represented by proxy at the ~~meeting and various other details related to the meeting; and~~Meeting.

~~ii.~~This AReport ~~Proxy~~on ~~Card~~Form ~~whereby~~6-K is ~~holders~~incorporated ofby ~~Company~~reference into the Registrant’s ~~shares~~registration ~~may~~statements ~~vote~~on atForm S-8 (File Nos. 333-260878 and 333-278130) filed with the ~~meeting~~SEC ~~without~~on ~~attending~~November in8, ~~person~~2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

This Report on Form 6-K, and the exhibits hereto, excluding the letter from the Company’s Chief Executive Officer, are incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

Exhibit Index

Exhibit		Description
99.1		Notice and Proxy Statement for the Company’s Annual General Meeting of Shareholders to be held on September 19, 2025.
99.2		Proxy Card for the Company’s Annual General Meeting of Shareholders to be held on September 19, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.
August 15, 2025	By:	/s/ Ayala Berler Shapira
September 22, 2025	By:	/s/ Ayala Berler Shapira
		Ayala Berler Shapira, Adv.
		Ayala Berler Shapira
		General Counsel

3 2

Filing Compare · Cellebrite DI Ltd.